In this study, we investigated the functional role of the localization of human OTR in caveolin-1 enriched membrane domains. Biochemical fractionation of MDCK cells stably expressing the WT OTR-GFP indicated that only minor quantities of receptor are partitioned in caveolin-1 enriched domains. However, when fused to caveolin-2, the OTR protein proved to be exclusively localized in caveolin-1 enriched fractions, where it bound the agonist with increased anity and eciently coupled to Ga q/11 . Interestingly, the chimeric protein was unable to undergo agonist-induced internalization and remained con®ned to the plasma membrane even after prolonged agonist exposure (120 min). A striking dierence in receptor stimulation was observed when the OT-induced eect on cell proliferation was analysed: stimulation of the human WT OTR inhibited cell growth, whereas the chimeric protein had a proliferative eect. These data indicate that the localization of human OTR in caveolin-1 enriched microdomains radically alters its regulatory eects on cell growth; the fraction of OTR residing in caveolar structures may therefore play a crucial role in regulating cell proliferation.
Introduction
Caveolae are plasmalemmal invaginations whose membranes are enriched with caveolin proteins, glycosphingolipids and cholesterol (Anderson et al., 1992) . Although they were originally implicated in cell transport processes, recent evidence suggests that they are involved in signal transduction (Anderson, 1998; Okamoto et al., 1998; Simons and Toomre, 2000) . It has been reported that a number of signalling molecules, including heterotrimeric G proteins and heptahelical G protein-coupled receptors (GPCRs), are associated with caveolin-enriched membrane fractions, thus suggesting that GPCRs may compartmentalize within caveolae domains either permanently, as resident proteins, or transiently, at some stage during the activation and/or inactivation cycle. Studies of GPCR-caveolae interactions have so far revealed a complex and multifaceted, rather than a common theme, and so various hypotheses can be formulated to explain the functional role of GPCR targeting to caveolae: (i) sequestration in caveolae may be involved in turning o the GPCR-induced response and/or GPCR internalization; (ii) active GPCRs may be recruited to caveolae in order to facilitate their coupling with a high local concentration of downstream signalling partners; and (iii) the transient and/or partial localization of GPCRs in caveolar domains may regulate speci®c signal transduction pathways.
It has been shown that the mitogenic eects mediated by some GPCRs are related to endocytosis (Ceresa and Schmid, 2000; Pierce et al., 2001 ), but their dependence on a caveolar localization has not yet been investigated. The human oxytocin receptor (OTR) is especially intriguing because, although only one OTR encoding gene has been cloned and found to be expressed in dierent tissues and cell lines, oxytocin (OT) may stimulate, inhibit or have no eect on cell proliferation, depending on the cell system. Furthermore, these dierent eects seem to be mediated by dierent signalling pathways, including an increase in calcium, the formation of cAMP and the activation of MAP kinases. It is still unclear how a single receptor type can mediate such dierent responses (Bussolati and Cassoni, 2001 ), but one possible explanation is that human OTR may activate dierent transduction pathways depending on its localization in dierent membrane domains. The association of OTR with caveolin-enriched domains has so far been documented only in HEK293 cells (Gimpl and Fahrenholz, 2000) , but the consequences of this localization on signalling properties have not yet been investigated.
The aim of this study was to assess the functional role of the localization of human OTR in the caveolinenriched domains of transfected MDCK cells. Our results show that only a minor fraction of OTRs colocalizes with caveolin-1. However, the experimentally induced increase in the proportion of caveolaelocalized receptors has a profound consequence on the mitogenic eects of OT: when the vast majority of OTRs are excluded from caveolin-enriched domains, OT inhibits cell proliferation but, when OTRs were targeted to caveolae after being fused to caveolin-2, the hormone has a strong mitogenic eect. These ®ndings suggest that the fraction of OTRs compartmentalized in caveolae domains may in¯uence the proliferative/ antiproliferative eects of OT.
Results

Minor quantities of WT-OTR are partitionated in caveolin-1 enriched microdomains
To investigate the role of caveolar localization, we fused the full length WT OTR to the N-terminus of EGFP (Cormack et al., 1996) . As shown in Table 1 , radioreceptor binding and inositol phosphate (InsPs) accumulation assays indicated that the addition of the tag did not aect the pharmacological properties of the receptor in transiently transfected COS7 cells. In comparison with COS7 cells, the WT OTR-GFP expressed in MDCK cells shows a 15 ± 20-fold decrease in anity and EC50 values. These ®ndings may be explained by assuming that dierent cell types express dierent amounts and/or types of G-proteins and downstream eector molecules, which may in¯uence GPCR anities and coupling eciencies. We have previously reported that the EC 50 s of agonist-mediated InsP production may be dierent when the untagged WT OTR is expressed in dierent cell types (Chini et al., 1996) , and similar ®ndings have been reported for the related vasopressin V1a receptor (Thibonnier et al., 1994) .
After transfection in MDCK cells, a clone that stably expressed the WT OTR-GFP was used to investigate the association betwen the chimeric receptor and caveolae microdomains. As the partitioning of a protein in a Triton-insoluble, high buoyancy fraction of¯otation sucrose gradients (TIFF, Triton-insolublē oating fraction) is often used as an index of its association with glycosphingolipid/cholesterol-enriched membrane domains, we analysed the presence of WT OTR-GFP in TIFFs obtained from transfected MDCK cells. Western immunoblotting analysis of whole cell lysates using a polyclonal anti-GFP antibody showed that the WT-OTR-GFP fusion protein migrated on SDS ± PAGE as a major broad band with an apparent molecular mass of approximately 120 kDa (Figure 1a) . After sucrose density centrifugation of the cell extracts in 1% cold Triton, only minor proportions of WT OTR-GFP co-localized with caveolin-1 in fraction 5 of the gradient (at the interface between 5 and 35% sucrose) (Figure 1b) . The greatest proportions of the OTR-GFP fusion proteins were recovered in the bottom 8 ± 12 fractions (40% sucrose), which contain the bulk of membrane-associated and cytosolic proteins. Identical results were obtained after fractionating MDCK cells pre-exposed to 10 76 M OT for 2 or 15 min (data not shown). Taken together, these observations suggest that, in MDCK cells, only a minor proportion of the recombinant OTR-GFP fusion is associated with caveolin-enriched domains in the resting and agonist-induced states.
The WT OTR-GFP fused to caveolin-2 is targeted to caveolin-enriched microdomains Caveolin-1 and -2 are co-expressed to form heterooligomeric complexes in many cell types, including MDCK cells (Scheiele et al., 1998) . These heterooligomers represent the functional assembly units of higher-mass complexes that act as the structural skeleton of caveolae and as a scaold for caveolaeassociated polypeptides (Scheiele et al., 1998) . To test whether fusion with caveolin enables the incorporation of WT OTR-GFP into the caveolin scaold of living MDCK cells, we generated an MDCK clone constitu- . Inositol phosphate accumulation was determined as previously described (Kirk et al., 1986) . The data were analysed by means of non-linear regression using a sigmoidal dose-response equation (GraphPad Prism TM Figure 1a) . Furthermore, analysis of the partitioning of OTR-GFP-cav2 on¯otation sucrose gradients showed that it was entirely concentrated in TIFFs, together with the bulk of caveolin-1 (Figure 1b) , thus suggesting that it exclusively associated with caveolinenriched membrane domains.
As shown in Table 1 , binding experiments on intact cells indicated that OTR-GFP-cav2 has a signi®cantly higher anity for [ 3 H]OT (P50.05), with a K d value (1.31+0.69 nM; n=4), lower than that calculated for WT OTR-GFP in MDCK cells (18.36+5.22 nM; n=4), and that the overall surface density of OTR-GFP-cav2 sites is the same as that of WT OTR-GFP as indicated by their B max .
We then investigated receptor coupling to Ga q/11 by measuring agonist-induced InsP accumulation in WT OTR-GFP and OTR-GFP-cav2-expressing cells. There was no signi®cant dierence in either basal production (Figure 2a ) or the total InsP production induced by 10 mM OT ( Figure 2b ) and analysis of the doseresponse curves of total InsP accumulation, such as those shown in Figure 2c , indicated a non-signi®cant dierence in their EC 50 values (Table 1) . Furthermore, no change in the total InsP accumulation induced by 100 mM UTP was observed in the two cell types, thus indicating that the signalling of endogenous P2Y purinergic receptors coupled to Ga q/11 was unaected (Figure 2b) . Finally, Ga s and Ga i coupling was investigated by measuring cAMP formation upon application of OT or Thr 4 Gly 7 OT, a highly selective OTR agonist (Elands et al., 1988) . As shown in Figure 2d , OT and Thr 4 Gly 7 OT were unable to increase or decrease the intracellular cAMP levels in both the WT OTR-GFP and OTR-GFP-cav2 expressing cells, indicating that the dierent membrane compartmentalization did not aect the OTR coupling ecacy to Ga s or Ga i .
Recombinant WT OTR-GFP internalizes via a clathrincoated pit pathway, whereas the internalization of OTR-GFP-cav2 is impaired
Fusion with the GFP reporter allowed confocal microscopy visualization of the distribution of the OTR constucts in polarized MDCK cells. Horizontal and vertical sections (Figure 3a) showed that the WT OTR-GFP and OTR-GFP-cav2 are expressed on the baso-lateral surface of fully polarized MDCK cells where they co-localize with E-cadherin, a plasma membrane marker (Gumbiner et al., 1988) . The OTR-GFP-cav2 protein is thus recruited to areas of cell-cell contact as eciently as the WT receptor. Ultrastructural transmission electron microscopy examination of the cells stably expressing OTR-GFPcav2 showed no obvious alteration in the overall morphology nor any change in the number and localization of caveolae in comparison with untransfected MDCK cells or cells transfected with WT OTR-GFP (data not shown).
To establish whether WT OTR-GFP undergoes agonist-induced internalization in MDCK cells, we OT for increasing lengths of time (Figure 3b ). Before agonist exposure (T0), con¯uent cell monolayers expressing WT OTR-GFP were homogeneously¯uor-escent all around the cell edges. Punctate¯uorescence, presumably associated with endocytotic vesicles, could be seen as early as 5 min after agonist application and became more evident after 15 min; at 30 and 60 min, the¯uorescent patches appeared to be mainly localized in intracellular compartments. Such localization was also observed in cells treated with OT for 24 h (Figure 3c ). In order to determine which endocytic pathway is responsible for the internalization of WT OTR-GFP, we repeated the above experiments after incubating the cells in hypertonic medium to block clathrin-coated vesicle-mediated endocytosis (Hansen et al., 1993) . As shown in Figure  3d , the hypertonic treatment was extremely ecacious in preventing the OT-induced internalization of the WT OTR-GFP, thus indicating that the agonistinduced internalization of WT OTR-GFP takes place through the classical pathway involving clathrincoated vesicles. This ®nding is consistent with the presence of an YXXO motif in the C-terminal receptor sequence that is known to mediate the rapid clathrin-mediated internalization of plasma membrane proteins via interactions with AP complexes (Bonifacino and Dell'Angelica, 1999) . Furthermore, in a very recent study, the OTR has been shown to belong to the subgroup of GPCR that internalize via clathrin but fails to recycle back to the plasma membrane due to a persistent association with b-arrestin (Oakley et al., 2001) Even though the OTR-GFP-cav2 eciently binds the agonist and transduces its signal into second messenger production, the chimeric receptor remained permanently localized on the surface of the cells expressing OTR-GFP-cav2 after agonist application for up to 60 min (Figure 3e ) and 24 h (Figure 3c ), without any sign of endocytic vesicle formation. Co-localization with caveolin-1 was also maintained throughout the period of stimulation (Figure 3f ), thus suggesting that OTR-GFP-cav2 does not translocate out of caveolinenriched domains. The impairment of the agonistinduced internalization of OTR-GFP-cav2 was quantitatively con®rmed by measurements of the total OT were added at a ®nal concentration of 10 77 M. After 12, 24 and 48 h of treatment, the cells were ®xed and stained with 0.1% crystal violet; cell growth was evaluated by measuring absorbance at 590 nm. All of the experiments were done in triplicate. Statistical analysis was carried out by ANOVA (a) pEGFP-N3 vector, (b) WT OTR-GFP, (c) OTR-GFP-cav2, (d). Clone 3 WT OTR-GFP and OTR-GFP-cav2 indicate the original clones used in all of the experiments described so far; these clones were made to revert to a non-expressing phenotype (clone 3 WT OTR-GFP rev and OTR-GFP-cav2 rev) by means of several passages in G418 depleted medium. Clone 2 WT OTR-GFP and clone 7 OTR-GFP-cav2 indicate two additional clones stably expressing the receptors. Figure 4a , 120 min of OT pre-treatment led to only a 20% decrease in the number of high anity sites in the cells expressing the OTR-GFP-cav2 chimera, as against the 80% loss of binding observed in the cells transfected with WT OTR-GFP. Taken together, these results show that OTR-GFP-cav2 at the plasma membrane cannot escape the caveolin cage and does not undergo endocytosis through the clathrin-mediated route.
Since the OTR-GFP-cav2 receptors persisted at the cell surface after as long as 24 h of OT treatment (Figure 3c ), we investigated whether this permanence was associated with a defect in agonist-induced receptor desensitization. As shown in Figure 4b , 24-h pre-treatment with the agonist did not alter the OT-induced InsP accumulation in cells expressing the OTR-GFP-cav2, thus indicating that the OTR-GFPcav2 located in caveolin-1 enriched microdomains did not desensitize; on the contrary, as expected for a receptor undergoing agonist-induced desensitization, the OT-induced InsP accumulation of WT OTR-GFP decreased to basal level after 24 h of OT treatment.
Localization of the human OTR in caveolin-1 enriched microdomains turns receptor-mediated inhibition of cell growth into a proliferative response
After exposure to ®nal concentrations of 100 nM of OT or Thr 4 Gly 7 OT, negligible changes in cell growth were observed in MDCK cells transfected with pEGFP vector alone (Figure 5a ), whereas the agonist treatment of cells expressing WT OTR-GFP (Figure 5b ) signi®cantly inhibited cell growth at every time point, and signi®cantly stimulated the proliferation of OTR-GFPcav2-expressing cells even at the earliest time of treatment (12 h) (Figure 5c ). In order to rule out the possibility that the eects on cell proliferation might be due to clonal variability, two types of control experiments were performed. A negligible eect of agonists on cell proliferation was observed after the WT OTR-GFP and OTR-GFP-cav2 clones had reverted to a non-expressing phenotype after being maintained in a complete medium depleted of G418 antibiotic until they showed no GFP¯uorescence or speci®c [ OT respectively showed the inhibition and enhancement of cell proliferation (Figure 5d ). These results con®rm that the agonist-induced eects on cell proliferation are speci®cally due to the stimulation of the transfected receptors. Finally, we examined the OT dose-response curves of WT OTR-GFP and OTR-GFP-cav2 transfected cells (Figures 5e,f) , and found very similar values for the inhibitory eect on WT OTR-GFP (IC 50 =22.0+4.3 and 15+3.3 nM in two independent assays) and the OT-elicited stimulatory eect on OTR-GFP-cav2 (EC 50 =35.6+5.5 and 28+8.6 nM in two independent assays).
Discussion
Our data show that, when expressed in stably transfected MDCK cells, only a minor proportion of GFP-tagged human WT OTR co-localizes with caveolin-1, thus suggesting only a partial association with caveolae. These results fully agree with those reported by Gimpl and Fahrenholz (2000) , who showed that, depending on the detergent used, about 1 ± 15% of total WT OTR-GFP is associated with caveolin-1 enriched microdomains in HEK293 cells. However, even a partial association may be physiologically relevant since it has been shown that caveolar sequestration involving only a minor fraction of muscarinic M2 or b 2 adrenergic receptors may be crucial in mediating speci®c signalling functions (Dessy, 2000; Ostrom et al., 2000; Rybin et al., 2000) . In line with this view, we found that caveolae represent a membrane compartment in which OTR may accomplish speci®c signalling tasks responsible for the regulatory eects of OT on cell growth.
Compartmentalization eects were investigated by comparing MDCK cell line arti®cially engineered to express a high concentration of OTR-GFP-cav2 associated with caveolin-enriched domains, and the MDCK cell line in which the bulk of WT OTR-GFP is located outside caveolae. Since caveolin-2 is involved in the formation of hetero-oligomers with caveolin-1 in the endoplasmic reticulum, as well as in the sorting of these complexes to the baso-lateral membranes of MDCK cells in which caveolae normally reside (Scheiele et al., 1998) , we ®rst checked whether the addition of a caveolin-2 moiety to the C-terminal end of the OTR aected its intracellular tracking. The lack of agonist-induced internalization was the only major dierence observed in the tracking properties of the OTR-GFP-cav2 expressed in MDCK cells. The protein reached the plasma membrane as eciently as WT-OTR-GFP and no retention was observed in intracellular compartments. Furthermore, the protein was correctly sorted to the baso-lateral compartment in fully polarized cells. However, on the basis of our data, we cannot distinguish two possible mechanisms for the baso-lateral sorting of the OTR-GFP-cav2 protein: (1) the presence of an OTR dominant signal for basolateral localization that is also fully functional in OTR-GFP-cav2, and/or (2) a shuttle action of the caveolin-2 receptor moiety through the formation of oligomers with the caveolin-1 already in the endoplasmic reticulum.
As for the pharmacological properties of the WT OTR-GFP and OTR-GFP-cav2 proteins are concerned, we observed an increase in OT anity of the OTR sequestered in caveolar microdomains. Since it is known that OT anity of the OTR increases with the cholesterol content of the plasmamembrane (Gimpl and Fahrenholz, 2000; Klein et al., 1995) , the higher OT anity shown by the OTR-GFP-cav2 may be explained by its localization in microdomains enriched in caveolin-1 as well as in cholesterol (Hailstones et al., 1998) . However, to this increased OT anity did not correspond a decreased EC50 value for OT induced InsP accumulation. The simplest explanation for this ®nding is that the caveolin-2 moiety at the C-terminus of the receptor aects by steric hindrance the binding of the Ga(GDP)/bg complex to the intracellular regions of the receptor, thus lowering the receptor coupling ecacy.
The most relevant biological eect of the localization of OTR in caveolin-1 enriched microdomains is the change in its mitogenic capability, a phenomenon that may depend on a number of dierent mechanisms.
Caveolae localization may favour coupling to dierent G protein-mediated signalling cascades. It has been shown that OTRs couple to Ga q/11 alone, to Ga i and Ga q/11 , or to Ga i and Ga s in myometrial cells (Hoare et al., 1999; Strakova and Solo, 1997) , and that the inhibitory eects on the proliferation of breast cancer and glial cells are associated with an increase in intracellular cAMP levels (Cassoni et al., 1997 (Cassoni et al., , 1998 . Furthermore, since OT promotes the synthesis of prostaglandins in a number of cell systems, some OTmediated eects on cell proliferation may be indirectly mediated by an autocrine/paracrine loop involving the activation of Ga s -coupled prostaglandin receptors, thus leading to increased cAMP production and the inhibition of proliferation. However, as agoniststimulated WT OTR-GFP and OTR-GFP-cav2 were equally ecient in mediating InsP accumulation, and neither could drive an increase in intracellular cAMP concentrations, we ruled out the possibility that they may be dierentially coupled to Ga q-11 or Ga s proteins. Similarly, the lack of inhibition of intracellular cAMP accumulation when OT was co-applied with forskolin indicates that the OTR-GFP-cav2 coupling to Ga i was not enhanced in comparison with that of WT OTR-GFP.
MAPK are key regulators of cell proliferation, and their activation can lead to opposite biological eects (proliferation or inhibition of cell growth/dierentiation or de-dierentiation) depending on whether the activation is long-lasting or transient, or the upstream eectors involved (Gutkind, 1998; Lewis et al., 1998; Pierce et al., 2001) . It can therefore be hypothesized that the activation of OTR in dierent membrane compartments may activate MAPK with either dierent kinetics and/or via dierent pathways. A recent study has shown that, when the PAR2 receptor (a Ga q coupled GPCR) activates ERK1/ERK2 via a Rasindependent and PKC-dependent pathway, the MAPK does not translocate to the nucleus and fails to exert any mitogenic eect; on the contrary, a PAR2 receptor mutant that activated ERK1/ERK2 via a Rasdependent pathway induced their translocation to the nucleus and cell proliferation (DeFea et al., 2000) . It is interesting to note that this PAR2 mutant showed the same defective internalization and desensitization as the OTR-GFP-cav2 mutant described here. Since human OTR activates the p42/44 and p38 MAPK pathways via both sensitive and insensitive PTX signalling pathways (Hoare et al., 1999; Ohmichi et al., 1995; Strakova et al., 1998) , it can be hypothesized that OTR localized in caveolar domains activate the MAP kinase in a Ras-dependent pathway leading to the activation and translocation of ERK1/ERK2 and cell proliferation, whereas the inhibition of cell growth may be associated with PLC-and PCK-dependent and Ras-independent activation. Experiments using inhibitors of the dierent signalling pathways potentially involved in MAPK activation by OTR-GFP-cav2 or WT OTR-GFP are currently under way in order to test this hypothesis.
In conclusion, our results provide the ®rst evidence that the localization of a GPCR in caveolin-1 enriched microdomains may have major consequences for its agonist-mediated eects on cell proliferation. It remains to be established if caveolar localization is a general way of modulating the mitogenic properties of other GPCRs and what signalling pathways are involved.
Materials and methods
Peptides and reagents
The synthetic peptides came from Bachem, Switzerland. The origins of the primary antibodies were as follows: polyclonal anti-caveolin-1 (no. sc-894) from Santa Cruz Biotechnology Inc.; monoclonal anti-caveolin-2 (no. 57820) from BD Transduction; polyclonal anti-Green Fluorescent Protein (GFP) from MBL (no. 598); monoclonal anti-E-cadherin (no. U3254) from Sigma; the monoclonal anti-clathrin antibody was puri®ed from ATCC X22 hybridoma cell line (no. CRL-2228).
Generation of fusion constructs and transfection
To obtain the wild type (WT) OTR-GFP construct, the human OTR cDNA was inserted into a pEGFP-N3 vector (Clontech). The OTR-GFP-cav2 construct was obtained by PCR. Brie¯y, a PCR product carrying at its 5' end the last few aminoacids of EGFP including a BsrgI site and at its 3' end a NotI site, was ampli®ed from a full length human caveolin-2 cDNA (gift of Dr MP Lisanti, A. Einstein Coll. Med., NY, USA), cut with BsrgI and NotI and ligated into a BsrgI-NotI cut WT OTR-GFP.
The COS7 cells were grown and transfected as previously described (Chini et al., 1995) . The MDCK cells, obtained from Dr G Pietrini (Milan, Italy), were transfected using the LipofectAmine reagent (GibcoBRL); the resistant clones were selected using G418 (600 mg/ml) and collected using cloning rings (Sigma). For the biochemical, pharmacological and immuno¯uorescence studies, the cells were seeded at a density of about 40 000 cells/cm 2 and routinely used on the 5th day following seeding.
Receptor binding assay
The cells were subcultured into 24-well dishes, washed twice with binding buer (146 mM NaCl, 4.2 mM KCl, 0.5 mM MgCl 2 , 1.0 mM CaCl 2 , 10 mM HEPES base, 1% glucose, 0.018% L-tyrosine, 1% BSA, pH 7.4) and placed on ice. Increasing concentrations of OT were added in the presence of 5 ± 10 nM [ 3 H]OT, with or without 10 76 M unlabelled OT. After incubation at 48C for 2 h, the cells were washed three times with ice cold binding buer and solubilized with 0.5 N NaOH. The samples were transferred into scintillation vials and counted using a b-counter after the addition of 3.5 ml of scintillation cocktail (Ultima Gold, Packard). The binding isotherms were analysed using GraphPad Prism TM .
Inositol phosphate determination
Inositol phosphate (InsP) accumulation was measured as previously described (Chini et al., 1995; Kirk et al., 1986) . Brie¯y, the cells were labelled for 24 h with myo-[2-3 H]inositol, pre-incubated for 10 min at 378C in Krebs buer (146 mM NaCl, 4.2 mM KCl, 0.5 mM MgCl 2 , 1.0 mM CaCl 2 , 10 mM HEPES base, 1% (w/v) glucose, pH 7.4) supplemented with 10 mM LiCl and stimulated for 20 min with or without agonists. InsP was separated using a strong anionic exchange column (Dowex AG1X8, formate form, 200-400 mesh; Bio-Rad). At each concentration, a fraction containing inositol mono-, bis-, and tris-phosphate was collected, and its radioactivity content determined by liquid scintillation counting. This fraction is referred to as total InsP and expressed as DPM/well. The data were analysed by means of non-linear regression using a sigmoid dose-response equation (GraphPad Prism TM ).
cAMP accumulation assay
After transfection, the cells were grown in 10 cm petri dishes for 48 h, and then washed twice with PBS without Ca 2+ and Mg
, incubated for 15 min at 378C in PBS 7 supplemented with 4 mM EDTA, scraped o using a policeman and ®nally centrifuged. The pellet was resuspended at a density of 10 6 cells/ 90 ml in D-PBS supplemented with 5.5 mM 3-isobutyl-1-methylxanthine (IBMX) and aliquots of 90 ml were left for 15 min at 378C. The cells were then treated with assay buer (baseline), forskolin (2 mM) and/or agonists (10 77 M), and incubated for 10 min at 378C. cAMP accumulation was stopped by placing the tubes in liquid nitrogen and boiling for 5 min. The samples were then centrifuged for 8 min at 12 000 r.p.m. in an Eppendorf Centrifuge, and the supernatants were immediately used for the assay; cyclic AMP was quanti®ed by means of a competitive binding assay (Cyclic AMP [ 3 H] assay kit, Amersham-Pharmacia) according to the manufacturer's instructions.
Fluorescence microscopy
Cells grown on glass coverslips were washed twice with 10 mM sodium phosphate buer, pH 7.4, containing 150 mM NaCl (LS buer), and ®xed for 20 min at room temperature with 4% (w/v) paraformaldehyde in PBS. The ®xed cells were rinsed with LS buer and incubated with primary antibodies in GDB buer (20 mM sodium phosphate buer, pH 7.4, containing 450 mM NaCl, 0.1% (w/v) gelatin), containing 0.3% (v/v) Triton X-100, for 2 h at RT. After washing with 20 mM sodium phosphate buer, pH 7.4, containing 500 mM NaCl (HS buer), the samples were incubated for 1 h with secondary antibodies in GDB buer, sequentially washed with HS and LS buers, and mounted on glass slides with 90% (v/v) glycerol in PBS. The slides were observed under an MRC1024 BioRad confocal microscope. For the polarity studies, MDCK cells were grown to con¯uence for more than 5 days on 0.4 mm pore Transwell ®lter inserts (Costar).
Internalization assays
Cells grown in 6-well dishes were washed twice in serum-free medium and left for 30 min to equilibrate at 378C. OT was then added at a ®nal concentration of 10 76 M. At ®xed time intervals (5, 15, 30 and 60 min), the cells were processed for the binding or immuno¯uorescence assays. The inhibition of clathrin-mediated endocytosis was obtained by incubating the cells for 5 min in DMEM (without sodium bicarbonate) containing 20 mM HEPES and supplemented with 0.45 M sucrose (Hansen et al., 1993) .
Protein analysis
The cell proteins were resolved by means of a Laemmli discontinuous SDS-PAGE system (Laemmli, 1970) . After semi-dry transfer to nitrocellulose membranes, the blots were incubated overnight at 48C in TBS-T (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% (v/v) Tween 20), containing 5% powdered skim milk. The membranes were then incubated for 3 h with the primary antibodies diluted in TBS-T/milk and for 1.5 h with horseradish peroxidase-conjugated anti-mouse or rabbit IgG (Pierce) . The proteins were detected using the SuperSignal chemiluminescent substrate (Pierce) .
Preparation of caveolin-1 enriched sucrose-density fractions MDCK cells grown in 100 mm Petri dishes were scraped into 2 ml of MES-buered saline (MBS, 25 mM Mes, pH 6.5, 0.15 M NaCl) containing 1% (v/v) Triton X-100, and then homogenized by means of 10 strokes of a loose-®tting Dounce homogenizer. The homogenate was adjusted to 40% sucrose by adding 2 ml of 80% sucrose prepared in MBS and placed at the bottom of an ultracentrifuge tube. Two 4-ml layers of 30 and 5% sucrose in MBS were overlaid above the homogenate, and the gradients were centrifuged at 39 000 r.p.m. for 16 ± 20 h in a SW41 rotor (Beckman Instruments). A light-scattering band at the boundary between 5% and 30% sucrose contained caveolin-1 but excluded most other cell proteins. From the top of each gradient, 1-ml gradient fractions were collected to yield a total of 12 fractions. For Western immunoblotting, the gradient fractions were precipitated with trichloroacetic acid, and the protein contents assayed with the BCA reagent (Pierce) . After normalization, the proteins were separated by SDS ± PAGE and blotted onto nitrocellulose.
Cell growth assay
The cells were seeded in 48-multiwell plates (10 000 cells per well) and allowed to adhere for 24 h. OT and Thr 4 Gly 7 OT were then added to the medium at ®nal concentrations of 10 77 M for up to 48 h. All of the treatments were quadruplicated. After 12, 24 and 48 h of treatment, the cells were ®xed in 2.5% (v/v) glutaraldehyde, stained with 0.1% (w/v) crystal violet in 20% (v/v) methanol and solubilized in 10% (v/v) acetic acid. Cell growth was evaluated by measuring absorbance at 590 nm in a microplate reader (Multiskan bichromatic, Labsystem) A calibration curve was set up with known numbers of cells, and a linear correlation between absorbance and cell counts was established up to 1610 5 cells. Statistical analysis was carried out by means of ANOVA.
